Quadriga Biosciences, Inc.
Los Altos, CA
- UEI
- MM17KEAVW7L5
- CAGE
- 6ENW6
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- Los Altos, CA, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| QBS10072S for the treatment of brain metastatic triple-negative breast cancer | National Cancer Institute (NIH) | $5,137,288 | |
| Novel chemotherapeutics for brain tumors | National Institutes of Health | $288,099 | |
| Novel targeted chemotherapeutics for gliobastoma | National Cancer Institute (NIH) | $8,723,055 |
Quick answers
Is Quadriga Biosciences, Inc. registered in SAM.gov?
Yes. Quadriga Biosciences, Inc.'s SAM.gov registration is active through May 29, 2027.
What is Quadriga Biosciences, Inc.'s most recent federal award?
Quadriga Biosciences, Inc.'s most recent federal grant award is QBS10072S for the treatment of brain metastatic triple-negative breast cancer (R44CA257579), from National Cancer Institute (NIH), on September 1, 2021.
On GovTribe
See Quadriga Biosciences, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors